HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 281.55 billion as of April 2, 2025. Its market cap has increased by 0.25% in one year.

Market Cap

281.55B

Enterprise Value

n/a

Revenue

36.10B

Ranking

n/a

PE Ratio

595.67

Stock Price

20,050.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 281.55B, an increase of 234.06%. That is a compound annual growth rate of 13.87%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2025	281.55B	-16.80%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	240.12B	219.34%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	72.17T
Celltrion	36.29T
ALTEOGEN	18.97T
Yuhan	8,178.75B
SK Biopharmaceuticals	7,776.51B
HLB Co., Ltd.	7,225.34B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,449.36B

Market Cap Rankings